. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Mol Cancer Ther. 2015 Feb 11;14(3):779–787. doi: 10.1158/1535-7163.MCT-14-0228

Table 3.

Residual tumor growth following indicated treatments and the CSC frequency estimated in re-implantation assays in NOD-SCID mice

Treatment	Number of Cells	Tumors/ Implantations	CSC Frequency
Control	1000	3/3	23
Control	500	3/3
Control	100	3/3
GSI	1000	2/3	504
GSI	500	0/3
GSI	100	1/3
Docetaxel	1000	3/3	88
Docetaxel	500	2/3
Docetaxel	100	2/3
GSI+Docetaxel	1000	0/3	1602
GSI+Docetaxel	500	0/3
GSI+Docetaxel	100	0/3